Evidence map›Paper›PMID 22386268›Full record

ArticleImmunity2012

B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity.

E Ashley Moseman, Matteo Iannacone, Lidia Bosurgi, Elena Tonti, Nicolas Chevrier, Alexei Tumanov, Yang-Xin Fu, Nir Hacohen, Ulrich H von Andrian

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 152 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Exploring CD169Vaccines · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Lymph node macrophages drive innate immune responses to enhance the anti-tumor efficacy of mRNA vaccines.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Single cell profiling of CD45Journal of neuroinflammation · 2022
    Article
  18. CD169European journal of immunology · 2022
    Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

E Ashley MosemanImmune Disease Institute and Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA.
Matteo Iannacone
Lidia Bosurgi
Elena Tonti
Nicolas Chevrier
Alexei Tumanov
Yang-Xin Fu
Nir Hacohen
Ulrich H von Andrian
Harvard University · USMassachusetts General Hospital · USTrudeau Institute · USUniversity of Chicago · USVita-Salute San Raffaele University · IT

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
THE A(1,3)FUCOSYLTRANSFERASE GENES AND SELECTIN LIGAND EXPRESSIONP01CA071932 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI FUKUDA, MINORU · 1996 to 2012
$15.5M
Visualizing Effects of Costimulation on Antiviral ImmunityP01AI078897 · NIAID · HARVARD MEDICAL SCHOOL · PI VON ANDRIAN, ULRICH H · 2008 to 2012
$12.1M
TRAINING PROGRAM IN MOLECULAR HEMATOLOGYT32HL007623 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI HANDIN, ROBERT I · 1985 to 2010
$7.0M
T Cell Activation in Lymph NodesR01AI069259 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI VON ANDRIAN, ULRICH H · 2006 to 2015
$4.5M
Differentiation and Regulation of CTLR01AI072252 · NIAID · HARVARD MEDICAL SCHOOL · PI VON ANDRIAN, ULRICH H · 2007 to 2011
$2.1M
NCI NIH HHS P01 CA071932NHLBI NIH HHS 5T32-HL07623-20NHLBI NIH HHS T32 HL007623NIAID NIH HHS AI069259NIAID NIH HHS AI072252NIAID NIH HHS AI078897NIAID NIH HHS P01 AI078897NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI069259NIAID NIH HHS R01 AI072252
6 · The paper itself

Abstract

Neutralizing antibodies have been thought to be required for protection against acutely cytopathic viruses, such as the neurotropic vesicular stomatitis virus (VSV). Utilizing mice that possess B cells but lack antibodies, we show here that survival upon subcutaneous (s.c.) VSV challenge was independent of neutralizing antibody production or cell-mediated adaptive immunity. However, B cells were absolutely required to provide lymphotoxin (LT) α1β2, which maintained a protective subcapsular sinus (SCS) macrophage phenotype within virus draining lymph nodes (LNs). Macrophages within the SCS of B cell-deficient LNs, or of mice that lack LTα1β2 selectively in B cells, displayed an aberrant phenotype, failed to replicate VSV, and therefore did not produce type I interferons, which were required to prevent fatal VSV invasion of intranodal nerves. Thus, although B cells are essential for survival during VSV infection, their contribution involves the provision of innate differentiation and maintenance signals to macrophages, rather than adaptive immune mechanisms.

Indexed as

Adaptive ImmunityAnimalsAntibodies, NeutralizingAntibodies, ViralB-LymphocytesImmunity, InnateInterferon Type ILymph NodesLymphotoxin alpha1, beta2 HeterotrimerMacrophagesMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutSignal TransductionVesicular StomatitisAntibodies, NeutralizingAntibodies, ViralInterferon Type ILymphotoxin alpha1, beta2 Heterotrimer

Identifiers

PMID22386268
PMCPMC3359130
OpenAlexW2127936148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.